Market Fallers: Ashtead Group, Associated British Foods, AstraZeneca, Burberry Group

Burberry Group PLC
[shareaholic app="share_buttons" id_name="post_below_content"]

Shares of Ashtead Group plc ticker code: LON:AHT has slid -3.54% or -81 points during the course of today’s session so far. Market sellers were far from a positive bunch while the stock has been in play. The period high was 2266 while the low for the session was 2206. The amount of shares exchanged has so far reached 609,814 while the average shares exchanged is 1,406,617. The 52 week high price for the shares is 2461 some 174 points in difference to the previous days close of business and a 52 week low sitting at 1572.5 a difference of some 714.5 points. Ashtead Group plc now has a 20 moving average of 2214.77 and also a 50 day simple moving average now of 2248.7. The market capitalisation currently stands at £10,154.93m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Ashtead Group plc being recorded at Tuesday, September 10, 2019 at 2:43:41 PM GMT with the stock price trading at 2206 GBX.

Shares in Associated British Foods plc ticker code: LON:ABF has decreased -2.39% or -55 points in today’s trading session so far. Sellers did not seem confident during the trading session. The periods high has reached 2313.09 dropping as low as 2227. The total volume of shares exchanged through this period comes to 454,365 with the average number of shares traded daily being 991,706. The 52 week high for the shares is 2659 around 354 points difference from the previous close and the 52 week low at 2011 is a variance of 294 points. Associated British Foods plc has a 20 day moving average of 2315.56 with a 50 day simple moving average now of 2372.06. The current market capitalisation is £17,796.84m at the time of this report. Share price is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Associated British Foods plc being recorded at Tuesday, September 10, 2019 at 2:43:23 PM GMT with the stock price trading at 2250 GBX.

The trading price for AstraZeneca plc with EPIC code: LON:AZN has slid -2.74% or -192 points during today’s session so far. Investors have so far given a mostly negative outlook during the trading session. The periods high has already touched 6990 meanwhile the session low reached 6756. The total volume traded so far comes to 1,130,027 whilst the average number of shares exchanged is 2,124,522. The stock 52 week high is 7583 around 579 points difference from the previous days close and putting the 52 week low at 5312 a difference of some 1692 points. AstraZeneca plc now has a 20 simple moving average of 7402.52 and the 50 day MA at 7034.82. This puts the market cap at £89,352.34m at the time of this report. The stock is traded in GBX. Mcap is measured in GBP. This article was written with the last trade for AstraZeneca plc being recorded at Tuesday, September 10, 2019 at 2:44:08 PM GMT with the stock price trading at 6812 GBX.

The trading price for Burberry Group plc with company EPIC: LON:BRBY has stepped down -3.72% or -83 points throughout the session so far. Traders have not remained optimistic during the session. The periods high has reached 2234 meanwhile the session low reached 2146. Volume total for shares traded at this point reached 519,591 with the daily average number around 1,363,060. A 52 week high for the stock is 2362 some 130 points in difference to the previous days close of business and a 52 week low sitting at 1618.5 a difference of some 613.5 points. Burberry Group plc has a 20 day moving average of 2189.17 and also a 50 day simple moving average now of 2183.18. This puts the market capitalisation now at £8,842.49m at the time of this report. The currency for this stock is GBX. Market cap is measured in GBP. This article was written with the last trade for Burberry Group plc being recorded at Tuesday, September 10, 2019 at 2:43:26 PM GMT with the stock price trading at 2149 GBX.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:
    AstraZeneca Plc commits $3.5 billion to boost US research and manufacturing by 2026, creating jobs and expanding its innovation footprint.
    AstraZeneca and Amgen's Tezspire shows promise in reducing nasal polyp size and congestion, offering hope for chronic rhinosinusitis patients.
    Associated British Foods plc reports strong financial results for the year ending 14 September 2024, showcasing impressive profitability and growth in various sectors.
    AstraZeneca's Wainzua gains CHMP backing for EU approval in treating ATTRv-PN, marking a potential breakthrough with self-administered therapy.

      Search

      Search